Riociguat, ≥99%
Product Name： Riociguat
CAS號(hào)：625115-55-1
分子式：C20H19FN8O2
分子量：422.42
貯存： 儲(chǔ)存溫度-20°C
可溶性： DMSO
生化和生理學(xué)機(jī)理：
Riociguat (BAY 63-2521; BAY 632521) is a novel drug that is currently in clinical development by Bayer. Riociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC). At the moment Phase III clinical trials investigate the use of riociguat as a new approach to treat two forms of pulmonary hypertension (PH)： chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class of sGC stimulators.
